FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072822904> ?p ?o ?g. }

• W2072822904 endingPage "466" @default.
• W2072822904 startingPage "461" @default.
• W2072822904 abstract "Reversible Posterior Leukoencephalopathy Syndrome was introduced into clinical practice in 1996 in order to describe unique syndrome, clinically expressed during hypertensive and uremic encephalopathy, eclampsia and during immunosuppressive therapy [1]. First clinical investigations showed that leucoencephalopathy is major characteristic of the syndrome, but further investigations showed no significant destruction in white cerebral tissue [2, 3, 4]. In majority of cases changes are localise in posterior irrigation area of the brain and in the most severe cases anterior region is also involved. Taking into consideration all above mentioned facts, the suggested term was Posterior Reversible Encephalopathy Syndrome (PRES) for the syndrome clinically expressed by neurological manifestations derived from cortical and subcortical changes localised in posterior regions of cerebral hemispheres, cerebral trunk and cerebellum [5].Patient, aged 53 years, was re-hospitalized in Cardiovascular Institute Dediwe two months after successful aorto-coronary bypass performed in June 2001 due to the chest bone infection. During the treatment of the infection (according to the antibiogram) in September 2001, patient in evening hours developed headache and blurred vision. The recorded blood pressure was 210/120 mmHg so antihypertensive treatment was applied (Nifedipin and Furosemid). After this therapy there was no improvement and intensive headache with fatigue and loss of vision developed. Neurological examination revealed cortical blindness and left hemiparesis. Manitol (20%, 60 ccm every 3 hours) and i.v. Nytroglicerin (high blood pressure). Brain CT revealed oedema of parieto-occipital regions of both hemispheres, more emphasized on the right. (Figure 1a, b, c). There was no sign of focal ischemia even in deeper sections (Figure 1d, e, f). Following three days enormous high blood pressure values were registered. On the fourth day the significant clinical improvement occurred with lowering of blood pressure, better mental state and better vision. There was no sign of left hemiparesis on the 7th day. On the 9th day there were no symptoms or sign of disease. Control brain CT (15th day) was normal. ETHIOPATHOGENESIS: Most common causes of PRES are hypertensive encephalopathy [6-8], pre-eclampsia/eclampsia [9-12] cyclosporin A administration [13-22] and uremic encephalopathy [23]. There are several theories about the mechanism for PRES in hypertensive encephalopathy (reversible vasospasm and hyperperfusion) and administration of cyclosporin A (neurotoxic effect).Most common symptoms are headache, nausea, vomiting, confusion, behavioural changes, changes of conciousness (from somnolencia to stupor), vision disturbances (blurred vision, haemianopsia, cortical blindness) and epileptic manifestations (mostly focal attacks with secondary generalisation). Mental functions are characterised with decreased activity and reactivity, confusion, loss of concentration and mild type of amnesia. Lethargy is often initial sign, sometimes accompanied with phases of agitation. Stupor and coma rarely occurred.In patients with hypertensive encephalopathy and eclampsia high blod pressure is registered. Neurological examination revealed vision changes and damages of mental function as well as increased reflex activity. Today, brain MRI and CT are considered the most important diagnostic method for the diagnosis and follow-up of patients with PRES [6]. Brain MRI better detects smaller focal parenhim abnormalities than brain CT. The most often neuroradiological finding is relatively symmetrical oedema of white cerebral tissue in parieto-occipital regions of both cerebral hemispheres. Gray cerebral tissue is sometimes involved, usually in mild form of disease. Diagnosis of this cortical form of PRES is possible by MR FLAIR (Fluid-Attenuated Inversion Recovery) technique [5].Therapeutic strategy depends on the cause of PRES and clinical picture. Most important are blood pressure regulation (labetalol, nitroprusid, diuretici), control of epileptic attacks (phenytoin), anti-oedema therapy. (Manitol), Induction of vaginal delivery in eclampsia and discontinuation of cyclosporin therapy. In most cases there are no neurological manifestations after the 7th day, but some studies showed normalisation of clinical finding after one year and more." @default.
• W2072822904 created "2016-06-24" @default.
• W2072822904 creator A5014960960 @default.
• W2072822904 creator A5017338859 @default.
• W2072822904 creator A5022120932 @default.
• W2072822904 creator A5068158513 @default.
• W2072822904 creator A5075057728 @default.
• W2072822904 date "2003-01-01" @default.
• W2072822904 modified "2023-10-17" @default.
• W2072822904 title "Posterior reversibile encephalopathic syndrom: case report and review of literature" @default.
• W2072822904 cites W144396922 @default.
• W2072822904 cites W1973221664 @default.
• W2072822904 cites W1975759226 @default.
• W2072822904 cites W1983687348 @default.
• W2072822904 cites W2004302019 @default.
• W2072822904 cites W2007335987 @default.
• W2072822904 cites W2011017461 @default.
• W2072822904 cites W2031736899 @default.
• W2072822904 cites W2042677231 @default.
• W2072822904 cites W2055732808 @default.
• W2072822904 cites W2067147435 @default.
• W2072822904 cites W2142829905 @default.
• W2072822904 cites W2167845206 @default.
• W2072822904 cites W2326297993 @default.
• W2072822904 doi "https://doi.org/10.2298/sarh0312461p" @default.
• W2072822904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15114789" @default.
• W2072822904 hasPublicationYear "2003" @default.
• W2072822904 type Work @default.
• W2072822904 sameAs 2072822904 @default.
• W2072822904 citedByCount "6" @default.
• W2072822904 countsByYear W20728229042012 @default.
• W2072822904 countsByYear W20728229042013 @default.
• W2072822904 crossrefType "journal-article" @default.
• W2072822904 hasAuthorship W2072822904A5014960960 @default.
• W2072822904 hasAuthorship W2072822904A5017338859 @default.
• W2072822904 hasAuthorship W2072822904A5022120932 @default.
• W2072822904 hasAuthorship W2072822904A5068158513 @default.
• W2072822904 hasAuthorship W2072822904A5075057728 @default.
• W2072822904 hasBestOaLocation W20728229041 @default.
• W2072822904 hasConcept C119767625 @default.
• W2072822904 hasConcept C126322002 @default.
• W2072822904 hasConcept C126838900 @default.
• W2072822904 hasConcept C141071460 @default.
• W2072822904 hasConcept C143409427 @default.
• W2072822904 hasConcept C187212893 @default.
• W2072822904 hasConcept C2776882386 @default.
• W2072822904 hasConcept C2777605182 @default.
• W2072822904 hasConcept C2778621155 @default.
• W2072822904 hasConcept C2779159986 @default.
• W2072822904 hasConcept C2779234561 @default.
• W2072822904 hasConcept C2779949217 @default.
• W2072822904 hasConcept C2780643987 @default.
• W2072822904 hasConcept C2780929884 @default.
• W2072822904 hasConcept C2781276381 @default.
• W2072822904 hasConcept C2781458274 @default.
• W2072822904 hasConcept C42219234 @default.
• W2072822904 hasConcept C54355233 @default.
• W2072822904 hasConcept C71924100 @default.
• W2072822904 hasConcept C84393581 @default.
• W2072822904 hasConcept C86803240 @default.
• W2072822904 hasConceptScore W2072822904C119767625 @default.
• W2072822904 hasConceptScore W2072822904C126322002 @default.
• W2072822904 hasConceptScore W2072822904C126838900 @default.
• W2072822904 hasConceptScore W2072822904C141071460 @default.
• W2072822904 hasConceptScore W2072822904C143409427 @default.
• W2072822904 hasConceptScore W2072822904C187212893 @default.
• W2072822904 hasConceptScore W2072822904C2776882386 @default.
• W2072822904 hasConceptScore W2072822904C2777605182 @default.
• W2072822904 hasConceptScore W2072822904C2778621155 @default.
• W2072822904 hasConceptScore W2072822904C2779159986 @default.
• W2072822904 hasConceptScore W2072822904C2779234561 @default.
• W2072822904 hasConceptScore W2072822904C2779949217 @default.
• W2072822904 hasConceptScore W2072822904C2780643987 @default.
• W2072822904 hasConceptScore W2072822904C2780929884 @default.
• W2072822904 hasConceptScore W2072822904C2781276381 @default.
• W2072822904 hasConceptScore W2072822904C2781458274 @default.
• W2072822904 hasConceptScore W2072822904C42219234 @default.
• W2072822904 hasConceptScore W2072822904C54355233 @default.
• W2072822904 hasConceptScore W2072822904C71924100 @default.
• W2072822904 hasConceptScore W2072822904C84393581 @default.
• W2072822904 hasConceptScore W2072822904C86803240 @default.
• W2072822904 hasIssue "11-12" @default.
• W2072822904 hasLocation W20728229041 @default.
• W2072822904 hasLocation W20728229042 @default.
• W2072822904 hasLocation W20728229043 @default.
• W2072822904 hasOpenAccess W2072822904 @default.
• W2072822904 hasPrimaryLocation W20728229041 @default.
• W2072822904 hasRelatedWork W2025573883 @default.
• W2072822904 hasRelatedWork W2072822904 @default.
• W2072822904 hasRelatedWork W2207159551 @default.
• W2072822904 hasRelatedWork W2256858874 @default.
• W2072822904 hasRelatedWork W2315713895 @default.
• W2072822904 hasRelatedWork W2334619860 @default.
• W2072822904 hasRelatedWork W2373197474 @default.
• W2072822904 hasRelatedWork W2464717443 @default.
• W2072822904 hasRelatedWork W2597492706 @default.
• W2072822904 hasRelatedWork W2790826126 @default.
• W2072822904 hasVolume "131" @default.

• next